FDA Panel Supports Pfizer Vaccine For Children 5-11

Check-in with us every morning as we kick off 90 minutes of Non-Stop ’90s at 8:00 am! @Totally939Miami! - #MackInTheMorning @MACKONTHERADIO & @iAmLettyB

An FDA advisory panel has officially endorsed the Pfizer COVID-19 vaccine for children ages 5-11.

The panel made a unanimous decision on Tuesday, which now goes to the FDA for its final ruling, due sometime in the coming days.

If approved, the vaccine would be a smaller dose than the one given to adults - just 10 micrograms compared to 30 in the full vaccine. Just like the adult vaccine, it would be given in two doses, three weeks apart.